Stem cells aid spinal cord injured-mice
Posted on: Tuesday, 20 September 2005, 07:40 CDT
By Will Boggs, MD
NEW YORK (Reuters Health) - Human neural stem cells can replace damaged cells and improve function in a mouse model of spinal cord injury, according to a report released Monday.
For treating spinal cord injury, "there is hope, but we are a long way off," Dr. Brian J. Cummings from University of California, Irvine, told Reuters Health. "Our study improved function in mice with very controlled injuries. We did not cure these mice."
Cummings and colleagues injected human neural stem cells into the site of spinal cord contusion injury in mice and followed their progress.
The human cells survived and engrafted extensively within the injured mouse spinal cord, the authors report, with cells persisting 17 weeks after transplantation.
Injected neural stem cells differentiated into neurons and formed synapses -- connections between neurons, the researchers note.
Mice injected with human neural stem cells showed evidence of recovering coordinated locomotor function and stepping ability 16 weeks after engraftment, the report indicates.
"To our knowledge," the investigators write, "this is the longest time that mice receiving stem cell grafts of any type have been tracked behaviorally."
Treatment of mice with toxin targeting the human cells resulted in decreased locomotor function, the results indicate. "This suggests that at least some of the recovery was the result of integration between the grafted cells and the host cells," Cummings said.
Summing up, Cummings said future treatments for spinal cord injury will likely involve a combination of therapies noting that "spinal cord injury is a very complex syndrome, and no one treatment will solve the entire problem."
SOURCE: PNAS Early Online Edition, September 19, 2005.
Source: REUTERS
Related Articles
- Immune Response to Human Embryonic Stem Cells in Mice Suggests Human Therapy May Face Challenge, Stanford Study Shows
- International Stem Cell Corporation and Novocell, Inc. Collaborate to Test Human Parthenogenetic Stem Cells for Production of Pancreatic Islet Cells That May Be Useful in the Treatment of Diabetes
- International Stem Cell Corporation's Human Parthenogenetic Stem Cells to Be Used in the Development of Treatments for Liver Disease
- International Stem Cell Corporation's Human Parthenogenetic Stem Cells to Be Used in Germany in the Development of Treatments for Neural Disease
- Journal of Neuroimmunology Publishes Study Results Showing That Geron's Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack By the Human Immune System
- Healtheuniverse Announces Patented Intellectual Property Utilizing Adult Stem Cells, Offers Alternative to Human Embryonic Stem Cells for Medical Treatment
- Research Indicates Geron's Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack By the Human Immune System
- Geron, University of Edinburgh Form Collaboration for Development of Three Cell Types Derived From Human Embryonic Stem Cells
- Geron Announces Publication of Study Results Supporting Safety and Utility of Human Embryonic Stem Cell-Derived Therapeutic Product for Treatment of Spinal Cord Injury
- Embryonic Death and the Creation of Human Embryonic Stem Cells
User Comments (0)


RSS Feeds